Is lipid-lowering therapy underused by African Americans at high risk of coronary heart disease within the VA health care system?

• Autores: LeChauncy D. Woodard, Nancy R Kressin, Laura A. Petersen
• Localización: American journal of public health, ISSN 0090-0036, Vol. 94, Nº. 12, 2004, págs. 2112-2117
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Objectives: We examined whether racial differences exist in cholesterol monitoring, use of lipid-lowering agents, and achievement of guideline-recommended low-density lipoprotein (LDL) levels for secondary prevention of coronary heart disease.; Methods: We reviewed charts for 1045 African American and White patients with coronary heart disease at 5 Veterans Affairs (VA) hospitals.; Results: Lipid levels were obtained in 67.0% of patients. Whites and African Americans had similar screening rates and mean lipid levels. Among the 544 ideal candidates for therapy, rates of treatment and achievement of target LDL levels were similar.; Conclusions: We found no disparities in cholesterol management. This absence of disparities may be the result of VA quality improvement initiatives or prescription coverage through the VA health care system.;